PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report.

Abstract Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process.
PMID
Related Publications

Effect of somatostatin in necrolytic migratory erythema of glucagonoma.

Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.

Necrolytic migratory erythema and pancreatic glucagonoma.

Glucagonoma syndrome associated with necrolytic migratory erythema.

Necrolytic migratory erythema.

Authors

Mayor MeshTerms

Single Photon Emission Computed Tomography Computed Tomography

Keywords
Journal Title medicine
Publication Year Start




PMID- 29390362
OWN - NLM
STAT- MEDLINE
DCOM- 20180212
LR  - 20180212
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Linking)
VI  - 96
IP  - 50
DP  - 2017 Dec
TI  - Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features:
      A case report.
PG  - e9252
LID - 10.1097/MD.0000000000009252 [doi]
AB  - RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a
      pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly 
      recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We
      report a case of a 68-year-old woman with a pancreatic glucagonoma. Her symptoms 
      at the onset were typical of the glucagonoma syndrome. DIAGNOSES: After a
      significant weight loss, she underwent a computer tomography scan of the abdomen,
      which showed a hypervascular lesion of the tail of the pancreas and hypervascular
      lesions of the liver. An ultrasound guided biopsy was performed and pathology was
      consistent with glucagonoma. Her blood glucagon levels were elevated. OUTCOMES:
      She was treated with chemotherapy and somatostatin analogs. After 4 years, the
      disease had a malignant transformation, and metastases suddenly started to grow
      up. She stopped being responsive to treatment and eventually passed away.
      LESSONS: Due to its rarity, clinical diagnosis is challenging and generally it
      comes after a long interval since the onset of symptoms. Awareness of physicians 
      and dermatologists of the characteristic necrolytic migratory erythema, and of
      the other symptoms, often leads to early diagnosis.
CI  - Copyright (c) 2017 The Authors. Published by Wolters Kluwer Health, Inc. All
      rights reserved.
FAU - Corrias, Giuseppe
AU  - Corrias G
AD  - Department of Radiology, Memorial Sloan Kettering Cancer Center, NY.
AD  - Department of Radiology, University of Cagliari, Cagliari, Italy.
FAU - Horvat, Natally
AU  - Horvat N
AD  - Department of Radiology, Memorial Sloan Kettering Cancer Center, NY.
AD  - Department of Radiology, Hospital Sirio-Libanes, Sao Paulo.
AD  - Department of Radiology, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
FAU - Monti, Serena
AU  - Monti S
AD  - IRCCS SDN, Naples, Italy.
FAU - Basturk, Olca
AU  - Basturk O
AD  - Department of Pathology.
FAU - Lin, Oscar
AU  - Lin O
AD  - Department of Pathology.
FAU - Saba, Luca
AU  - Saba L
AD  - Department of Radiology, University of Cagliari, Cagliari, Italy.
FAU - Bodei, Lisa
AU  - Bodei L
AD  - Department of Radiology, Memorial Sloan Kettering Cancer Center, NY.
FAU - Reidy, Diane L
AU  - Reidy DL
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
FAU - Mannelli, Lorenzo
AU  - Mannelli L
AD  - Department of Radiology, Memorial Sloan Kettering Cancer Center, NY.
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Radiopharmaceuticals)
RN  - 0 (indium-111-octreotide)
RN  - RWM8CCW8GP (Octreotide)
SB  - AIM
SB  - IM
MH  - Aged
MH  - Cell Transformation, Neoplastic/*pathology
MH  - Fatal Outcome
MH  - Female
MH  - Glucagonoma/*diagnostic imaging/*pathology
MH  - Humans
MH  - Liver Neoplasms/*diagnostic imaging/*pathology
MH  - Octreotide/analogs & derivatives
MH  - Pancreatic Neoplasms/*diagnostic imaging/*pathology
MH  - Radiopharmaceuticals
MH  - *Single Photon Emission Computed Tomography Computed Tomography
EDAT- 2018/02/03 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/03 06:00
PHST- 2018/02/03 06:00 [entrez]
PHST- 2018/02/03 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
AID - 10.1097/MD.0000000000009252 [doi]
AID - 00005792-201712150-00112 [pii]
PST - ppublish
SO  - Medicine (Baltimore). 2017 Dec;96(50):e9252. doi: 10.1097/MD.0000000000009252.